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ABSTRACT 
Jennifer Clayton Apple: Implementation of an evidence-based educational program to promote 
the correct use of a subdermal contraceptive implant 
(Under the direction of Diane Caruso) 
 
 Background: Unintended pregnancy remains one of the top problems women face across 
the United States, although the rate has decreased 18% in four years due to an increase in the use 
highly effective long acting reversible contraceptives (LARCs), specifically the subdermal 
implant. However, irregular or prolonged bleeding is the most common side effect associated 
with the subdermal implant and primary cause for early removal. Proper provider education on 
the management of side effects of the implant may improve how women tolerate the implant, 
decreasing rates of early removal. 
Purpose: The purpose of this project was to implement a system wide educational 
program for providers and staff at a local health department on optimizing counseling patients 
about the subdermal contraceptive implant to improve provider knowledge and decrease early 
removal rates.  
Methods: A quasi-experimental design based on Lippitt’s seven step theory was used to 
test the impact of a system wide educational intervention for providers on identifying irregular 
vaginal bleeding and potential treatments, and provision of provider contact information for 
patients receiving the subdermal implant. An informational brochure was also created as a tool 
for patients, and staff were educated on how to utilize the tool during patient encounters for 
implant insertion. Implementation consisted of education during in-person meetings with all staff 
 
 
iv 
members. Records of patients between January 1, 2017 to June 30, 2017 were randomly 
reviewed retrospectively and a 3-month post implementation chart review was conducted for 
comparison with pre-intervention data.   
 Results: The current project indicated the system wide educational intervention for 
providers and staff on optimizing counseling patients on the subdermal contraceptive implant 
and its common side-effects in females of childbearing age elicited a statistically significant 
change in knowledge among clinic staff at the NRC (Wilcoxon signed-ranked z = -2.371, p = 
0.018). There was also a significant impact on the number of subdermal implants removed (p = 
0.015) between pre and post implementation of the education program. 
 Conclusion: Implementation of a system wide educational program led to improved staff 
knowledge regarding evidence-based counseling for subdermal contraceptive implants. Based on 
these findings, standardizing provider-led education to counsel female patients on the subdermal 
contraceptive implant can lead to effective treatment of common side effects and reduce early 
discontinuation rates, ultimately preventing unwanted pregnancy. 
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To women everywhere, may you never feel inadequate or incapable. If you put your mind to it, 
you can accomplish anything. Nothing can stop a woman with a purpose.  
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CHAPTER 1: INTRODUCTION 
Background and Significance 
 In 2011, about 45% of all pregnancies in the United States (US) were unintended (Finer 
& Zolna, 2016). The number of unintended pregnancies per 1,000 women aged 15 to 44 years 
decreased substantially from 54 in 2008 to 45 in 2011, a decline of 18% (Finer & Zolna, 2016).  
This is the lowest rate of overall unintended pregnancy since 1981 (Finer & Zolna, 2016). The 
recent decrease in unintended pregnancies is likely due to increase in contraception use and 
highly effective methods, such as long acting reversible contraceptives (LARCs) (Finer & Zolna, 
2016). However, the rate of unintended pregnancies in the US remains the highest among 
developed countries (Jacobstein & Stanley, 2013). 
Long-acting reversible contraceptives (LARCs) include two types of intrauterine devices, 
the MirenaÒ or ParaGuardÒ (American College of Obstetricians and Gynecologists, 2017), and 
one type of implant, the NexplanonÒ (American College of Obstetricians and Gynecologists, 
2017). They provide highly effective contraception, rapid fertility reversal after removal, and are 
non-user dependent after placement.  LARCs are safe and highly effective contraceptive methods 
that prevent unintended pregnancy but are currently only being utilized by 5% of contraceptive 
users in the US (Secura, Allsworth, Madden, Mullersman, & Peiper, 2010).  NexplanonÒ, is a 
subdermal implant that is over 99% effective for up to 3 years (Nexplanon, 2017).   
Despite being highly effective and convenient, the subdermal implant has potential 
negative side effects, such as mood changes, headaches, weight gain, and acne.  Irregular or 
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prolonged bleeding is the most common negative effect reported with NexplanonÒ, with 
approximately 24% of implants discontinued early for this reason (Carek, Carr, Chirina, Diaz, & 
Dickerson, 2013).  These side effects may be tolerated better by patients if there is adequate 
education presented to them during their clinical visit so patients know what to expect and how 
to deal with it (Grentzer, McNicholas, & Peipert, 2014).  
 Donnelly, Foster, and Thompson (2014) found clinical counseling to be a primary factor 
of women’s contraceptive decision making.  Using an evidence-based education plan could help 
women considering discontinuation to instead receive safe, effective contraception for longer 
periods of time, ultimately providing more efficient, quality patient care and an overall decrease 
in subdermal implant contraceptive discontinuation rates (Akin, Ali, Bahamondes, Brache, 
Habib, & Landoulsi, 2016).  
Problem Statement 
 Poor tolerance to changes in vaginal bleeding associated with hormonal contraceptive use 
may influence compliance and continuation with the chosen method (Bachmann & Korner, 
2009).  Although the subdermal implant is generally well tolerated, a proportion of women will 
discontinue use because of unacceptable side effects, particularly frequent and/or prolonged 
irregular bleeding (Harvey, Seib, & Lucke, 2009).  
 Evidence confirms the need for extensive education to patients on the potential of 
irregular or prolonged bleeding when choosing the subdermal implant as their contraceptive 
choice (Moreau, Cleland, & Trussel, 2007; Lunde, Littman, Stimmel, Rana, Jacobs, & Horowitz, 
2017).  Counseling women on expected bleeding patterns has been shown to improve 
continuation rates for injectable and implantable progestogen contraceptives (Secura et al., 
2010).  At the time of placement, education should inform women of what to expect, including 
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irregular bleeding, what to do if bothersome side effects develop, and alternatives if the patient is 
no longer satisfied with the chosen contraceptive method (Moreau et al., 2007; Lunde et al., 
2017).  Clear written instructions should include management of possible side effects, ways to 
contact the provider if there are concerns, and reasons to return to the provider's office (Lunde, et 
al., 2017). The patients need to know and believe that the person who inserted the device is 
available for follow-up, including removal if needed, without judgement (Lunde, et al., 2017).  
Purpose of the DNP Project 
The purpose of this project was to implement a system wide educational program for 
providers and staff at a local health department on optimizing counseling patients about the 
subdermal contraceptive implant.  After meeting with providers at the Northern Regional Center 
(NRC), a problem of early termination rates was identified, and a quality improvement project 
was developed to educate the staff on effective patient counseling including correct use of the 
subdermal contraceptive implant, potential side effects, especially irregular vaginal bleeding, and 
the importance of providing contact information to patients during the clinic appointment.  The 
goal of the project was to see if this education program improved provider knowledge with 
educating patients on the correct use of subdermal implants. This project also compared early 
discontinuation rates of NexplanonÒ before and after the provider training session. Specifically, 
the current project addressed the following clinical questions: 
1. Will the implementation of a system wide educational program improve overall provider 
knowledge when optimizing counseling female patients age 18 through child bearing 
years about the subdermal contraceptive implant? 
 
 
4 
2. Will a system wide educational program that focuses on irregular vaginal bleeding and 
potential treatments, and provision of provider contact information reduce early 
discontinuation rates of the subdermal contraceptive implant? 
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CHAPTER 2: LITERATURE REVIEW  
Healthy People 2020 is a national initiative that has addressed eight reproductive health 
goals (Office of Disease Prevention and Health Promotion, 2018).  Increasing intended 
pregnancies is the first goal, with a target of a 10% improvement (Office of Disease Prevention 
and Health Promotion, 2018). Prevention of unintended pregnancy is of particular importance to 
the health and quality of life for women throughout the United States.  Inappropriate or 
inconsistent contraceptive use is the most common cause of unintended pregnancy, (Secura et al., 
2010) and approximately one in five unintended pregnancies ends in abortion (Pazol, Creanga, 
Burley, Hayes, & Jamieson, 2013). Due to the misuse or infrequent use of contraceptives, 
unintended pregnancy in the Unites States continues to be a persistent problem (Martinez, 
Copen, & Abma, 2011).  
Unintended Pregnancy 
The average US woman desires to have two children (Sonfield, Hasstedt, & Gold, 2014).  
This means that on average, about three years her life will be spent pregnant, postpartum, or 
attempting to become pregnant, while the remaining three-quarters of her reproductive life are 
spent trying to avoid an unintended pregnancy (Sonfield et al., 2014).  Even though there are 
many contraceptive choices available, 49% of the 6.4 million pregnancies every year in the 
United States are unintended (Trussell, 2007). Among women 15 to 44 years, the rate of 
unintended pregnancies was 51 per 1,000 women, with the majority occurring among women 
aged 18 to 24 (Trussell, 2007).   
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The US has established the Healthy People 2020 family planning goals to improve 
pregnancy planning and spacing and prevent unintended pregnancy (Office of Disease 
Prevention and Health Promotion, 2018). Unintended pregnancies may be further classified as 
either mistimed or unwanted.  Mistimed pregnancies are pregnancies that are undesired at the 
time of the pregnancy, but pregnancy may be desired at some point in the future.  These account 
for 27% of all pregnancies (Finer & Zolna, 2016).  Unwanted pregnancies occur if the pregnant 
woman does not want to become pregnant at that time or at any time in the future.  Unwanted 
pregnancies account for 18% of all pregnancies (Finer & Zolna, 2016).  Unintended pregnancies 
are associated with many negative health and economic consequences including depression, 
anxiety, and financial strain (Tsui, McDonald-Mosley, & Burke, 2010).   
Although several safe and highly effective contraceptives are available, nearly half of all 
pregnancies in the United States are unintended, with the majority occurring among women who 
are frequently college students, unmarried, low income, or not planning to conceive (Finer & 
Zolna, 2016; CDC, 2013).  Unintended pregnancies often result from inappropriate or 
inconsistent contraceptive use (Secura et al., 2010).  Highly under-utilized, LARC’s are safe and 
highly effective contraceptive methods that can be used to prevent unintended pregnancy (Secura 
et al., 2010; Mosher & Jones, 2010). 
Long-Acting Reversible Contraception (LARC) 
Counseling women on the use and availability of highly effective methods of 
contraception is an important role of providers during family planning (Stanback, Steiner, 
Dorflinger, Solo, & Cates, 2015).  LARCs, such as IUDs and the contraceptive implant are safe 
and effective forms of birth control, that should be the first line of contraception for women, 
when appropriate (American College of Obstetricians and Gynecologists, 2017). 
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very low as there is no daily, weekly, or monthly maintenance by the user (American College of 
Obstetricians and Gynecologists, 2017).  Several studies have shown a great deal of promise in 
decreasing teenage pregnancies with LARCs (Dodson, Gray, & Burke, 2012; Kohn, Hacker, 
Rousselle, & Gold, 2012).  Women also report a great deal of interest in LARCs and report high 
satisfaction with this contraceptive method (Dodson et al., 2012).  
Subdermal contraceptive implant. 
 Of the two types of LARCs available, the least commonly used is the subdermal implant 
(Daniels, Daugherty, Jones, & Mosher, 2015).  The subdermal implant is a single thin implant 
rod 4 cm long and 2 mm in diameter that is made of ethylene vinyl acetate and contains 68 mg of 
etonogestrel (3-keto-desogestrel), which is placed under the skin in the medial upper arm (Merck 
& Co. Inc., 2017).  It provides effective contraception with a very low level of progestin and 
follicular phase estrogen that has been well tolerated, has lower rates of weight change side 
effects and is a safer alternative to oral contraceptive pills (OCP) in women with certain medical 
conditions (Merck & Co. Inc., 2017). The hormones prevent the ovaries from releasing an egg 
and it also prevents fertilization by affecting the lining of uterus and thickening the cervical 
mucus (Merck & Co. Inc., 2017). The effectiveness of the implant to prevent pregnancy is 
greater than 99% (Merck & Co. Inc., 2017; Carek et al., 2013).   
 Birth control implants have been used worldwide for close to 20 years, are known as one 
of the most widely effective contraceptive methods available, and should be considered as first-
line contraceptive options among all women to reduce unintended pregnancy (Casner, Grunloh, 
Madden, Peipert, and Secura, 2013).  The NexplanonÒ, which replaced the birth control implant 
ImplanonÒ in 2010, is now shown to be effective at preventing pregnancy for up to 5 years, does 
not require maintenance other than having it changed according to schedule, and it cost little to 
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nothing for most patients with the Affordable Care Act (ACA) (Carek et al.,2013; Casner et al., 
2013; Fraser & Weisberg, 2005).  Most women agree that subdermal implants seem to be one of 
the most affordable, efficient, effective, and convenient contraceptive options for contraception 
in the 21st century (Fraser & Weisberg, 2005). 
 Although the efficacy rate of subdermal implants is 99%, the utilization rates of LARCs 
is poor (7.2%) compared with birth control pills (16.0%), female sterilization (15.5%), and male 
condoms (9.4%) (Carek et al., 2013; Daniels et al., 2015).  LARCs are the least common 
contraception used due to the perceived intolerable side effects leading to premature removal 
(Carek et al., 2013). 
Irregular Bleeding and Early Discontinuation 
Fifty percent of women who used subdermal implants as their contraception choice 
reported irregular or increased menstrual bleeding, and 24% had them removed early due to this 
(Carek et al., 2013). Although bleeding irregularities resulting from subdermal implant 
contraception do not affect the contraceptive’s efficacy, bleeding irregularities still remain a 
primary cause of discontinuation of this method (Bachmann & Korner, 2009).  Most irregular 
bleeding improves over time, and despite the bleeding, patient health is not detrimentally 
affected (Bahamondes, Critchley, Darney, Fraser, & Mansour, 2011).  
Although discontinuation rates are higher for contraceptives not requiring removal by a 
healthcare professional, discontinuation for all methods including subdermal implants are high 
(Glasier & Lakha, 2006). After one year of use, discontinuation rates varied from 19% with 
NorplantÒ to 62% with the combined pill (Glasier & Lakha, 2006). Guiahi, McBride, Sheeder, 
and Teal (2015) found extensive or prolonged menstrual bleeding to be significantly bothersome 
and inconvenient in 78% of females. This inconvenience also led 53% of females experiencing 
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the issue to consider early removal (Guiahi, 2015).  Many women using subdermal implants have 
reported such side effects, and have also reported that these led them to decide upon removal of 
the implants (Lunde et al., 2017).   
 Providers need to consider that the intolerable side effect of bleeding irregularity is a 
major reason for implant removal. Dickerson et al. (2013) found that 24% of women chose to 
remove the subdermal implant early due to irregular bleeding. Raising awareness of possible side 
effects among women using subdermal implants as contraceptive methods may lead to lower 
rates of premature implant removal (Dickson, Hoggart, & Newton, 2013).  These concerns may 
be partially alleviated through offering improved patient counseling services adequately 
information patients of specifications surrounding possible side effects (Lunde et al., 2017). 
Perhaps the most reassuring of reasons to use and increase use of subdermal implant 
contraception among patients in addition to efficacy, long duration and convenience is that 
implants have been clinically tested and deemed safe despite possible irregular bleeding 
(Grentzer et al., 2014). Subdermal implants have failure rates of <1%, similar to that of 
sterilization (Hatcher, Trussell, Nelson, Cates, Stewart, & Kowal, 2007). The unpleasant 
possibility of unpredictable bleeding may be tolerated more easily by patients when adequate 
education and counseling has been provided so that patients know exactly what to expect and 
how to deal with the possible side effects (Grentzer et al., 2014). Women who received 
structured counseling around irregular or prolonged bleeding had implant discontinuation rates 
of 26% less than those patients that did not received counseling (Grentzer et al., 2014).  
Role of Provider-Led Education 
 Education programs aimed at encouraging subdermal implant continuation within clinical 
practice are needed to increase LARC use among women (Bachmann & Korner, 2009; Carek et 
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al., 2013; Harvey et al., 2009). Sixty percent of implant discontinuations are the result of 
frequent and irregular bleeding following subdermal implants, therefore patient education 
surrounding this side effect is warranted (Dickson et al., 2014).  Lunde et al., 2017 conducted 
interviews with women using subdermal implants to identify themes around patient expectations 
for and experiences with the implants. Women stated they had not recalled being informed of 
possible side effects and participants also wanted tangible, personal evidence and examples of 
possible side effects before undergoing contraceptive use (Lunde et al., 2017).   
 Out of 111 women who received pre-implant education in the form of written material 
95% felt adequately counseled (Haugen, Evans, & Kim, 1996). They felt the reading material on 
benefits and side effects was an important part of the education process (Haugen et al., 1996). 
Lunde et al., 2017, completed a qualitative analysis of 16 female patients that had discontinued 
the implant contraception within 6 months of placement. They identified a major theme of the 
need for additional provider counseling at the time of placement (Lunde et al., 2017).  Patients 
needed to know and believe that the person who inserted the device was available for follow-up, 
including removal if needed, and that irregular bleeding decreased with time (Lunde et al., 2017).  
Women reported that having provider contact and follow-up helped them to decide against 
discontinuation (Lunde et al., 2017).  They also expressed the need for additional provider 
counseling aimed at understanding the possible side effects of subdermal contraceptive implants 
at the time of placement (Lunde et al., 2017).  
 Application of precise provider-led educational programs for subdermal implant users is 
shown to improve satisfaction and effectiveness. In a randomized control study by Garbers et al. 
(2012), precise educational messages administered through direct and personal counseling to 78 
women were found to be more effective for contraception compliance than generalized health 
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messages (95% compared to 77%). In addition, 86% of patients were more likely to continue 
contraception use with a personalized educational plan than with a general health message (86% 
compared to 69%) (Garbers et al., 2012). Users of subdermal implants in a study by Wong, Bell, 
McNameec, Thunuguntlaa, Vollenhovena, and Wonga (2009) reported a 95.3% satisfaction rate 
with ImplanonÒ when pre-implant patient counseling was given during their appointment. This 
level of satisfaction occurred despite side effects, highlighting the importance of counseling in 
the ongoing use of subdermal implants (Wong et al., 2009). 
Implementation of improved counseling and educational methods surrounding this choice 
of contraception could improve continuation rates positively contributing to the field of 
healthcare by diminishing unwanted pregnancies and providing quality patient care (Bachmann 
& Korner, 2009; Carek et al., 2013; Harvey et al., 2009).  Understanding patient preference and 
the rationales underlying patient choices is imperative to upholding and improving quality care 
and patient satisfaction (Coombe, J., Harris, M., & Loxton, D., 2016).  Exploring and using 
knowledge gained regarding patient preference to improve care and contraceptive use 
administered in clinical settings would likely improve patient outcomes by decreasing 
discontinuation rates and increasing patient satisfaction (Coombe et al., 2016).  
An improved educational program for patients before getting an implant placed, where 
providers do more than merely mention possible side effects is optimal (Dickson et al., 2014).  
Only 20% percent of women that discontinued the implant early were satisfied due to the 
unforeseen or intolerable side effects (Haugen et al., 1996).  Educational programs need to be 
more tangible and concrete that focus on the initial, uncomfortable side effects (Lunde et al., 
2017).  These educational measures can greatly improve women’s prolonged experience of 
subdermal implants such as NexplanonÒ (Haugen et al., 1996).  
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CHAPTER 3: THEORETICAL FRAMEWORK 
Using a scientifically-based theory to develop an evidence-based plan for implementing a 
successful practice change would ensure it meets the current standards of care and the needs of 
the constantly changing nursing and healthcare profession.  By integrating nursing science with 
biophysical, psychosocial, analytical, and organizational sciences to understand the nature of 
health and health care delivery, and evaluate the effectiveness of interventions, a thorough plan 
can be developed to ensure successful integration (Mitchell, 2013).  
Lippitt, Watson, and Westley (1958) created a seven-step process known as Lippitt’s 
Change Theory (Lippitt, Watson, & Westley, 1958). The theory focuses on the role and 
responsibility of the change agent and not the response to the change (Mitchell, 2013).  Seven 
phases make up the theory (1) diagnosing the problem; (2) assessing the motivation/capacity for 
change; (3) assessing the change agent’s motivation and resources; (4) selecting progressive 
change objective; (5) choosing the appropriate role of change agent; (6) maintaining change; (7) 
and terminating the helping relationship (Lippitt et al., 1958).  
Lippitt’s model identifies the problem and then ensures all stakeholders buy in to the 
change.  While Lippitt’s theory requires a greater level of understanding of change theory, it is 
likely to be more useful to medical staff because it incorporates a more detailed plan of how to 
generate change and it is underpinned by the four elements of the nursing process: assessment, 
planning, implementation, and evaluation (Lippitt et al., 1958). Nursing requires a more 
scientific-based approach to change, which Lippitt’s theory closely resembles. 
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Application of Lippitt’s Theory at the NRC 
To effect change at the NRC, Lippitt’s seven steps were used to assist with framing a 
process to decrease the number of patients who choose early discontinuation of the subdermal 
implant.  
Problem identification.  A problem identified was early discontinuation of the 
subdermal contraceptive implant (NexplanonÒ) due to dissatisfaction from irregular or 
prolonged bleeding and a lack of patient education on what to expect with this contraceptive.  
Assessing motivation and capacity for change. Several meetings took place with the 
providers and support staff at the NRC to create the awareness of the problem, assess the 
motivation for change, and provide encouragement to address the problem.   
Assessing the change agent’s motivations and resources.  After presenting the need for 
change in the clinic, the staff was motivated to change. All stakeholders, including the nurse 
practitioner and medical doctor at the clinic, and the Medical Director of Family Planning for the 
Wake County Health Department, were in support of the project. The research department and 
providers at the Northern Regional Center and faculty mentors at the University of North 
Carolina’s School of Nursing were also used as resources to help support the change. 
Change objectives. Another important step in the current project was selecting the 
change objective. The main change objective was to create an educational program to optimize 
provider-led counseling on correct use of the subdermal contraceptive implant and on evidence-
based counseling practices to reduce early discontinuation rates. 
Choosing the appropriate role for the change agent. An appropriate role for the change 
agent to meet these objectives was to create a system wide change with an educational program 
through a quality improvement project. This educational program provided a thorough review of 
 
 
14 
irregular vaginal bleeding and potential treatment options. In addition, a brochure was developed 
to give to patients during their clinic visit. The clinic previously offered nothing in written format 
for the patient to take home after the appointment for reference so this made the project 
sustainable. 
Maintaining the change. After implementation, the next task involved maintaining 
change through process re-evaluation, and providing the staff with the results of the change in 
order to implement it as permanent practice in the Northern Regional Center. The results were 
provided in tables through Microsoft WordÒ for their review. 
 Terminating relationship. Once change was completed, the change agent terminated 
the relationship. Patient education for subdermal implants was consistent throughout the clinic 
from all staff and each patient received the developed brochure. After positive feedback, the 
system chose to sustain the change. 
This model was established based on a business model but closely relates to practices in 
healthcare (Mitchell, 2013). With reimbursement being tied to health outcomes, health systems 
are starting to have more interest in business approaches (Mitchell, 2013).  Using Lippitt’s 
Change Theory model to develop a system wide practice change that improved provider 
education and counseling for the correct use of the subdermal contraceptive implant for patients 
and improved provider satisfaction based on the developed education plan provided a structured 
approach to this quality improvement project.   
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CHAPTER 4: METHODOLOGY 
Design  
 The project was a quasi-experimental design used to examine the effect of a system wide 
quality improvement program that focused on the providers and staff at the NRC to refine and 
augment patient education for the subdermal contraceptive implant.  A survey was given pre-and-
post implementation to assess provider knowledge on the subdermal contraceptive implant, 
NexplanonÒ.  A pretest knowledge survey (Appendix 3) was administered to the staff 
anonymously to determine current knowledge and practice and identify inconsistencies in the 
current system.  Based on survey results, the educational program was developed for specific 
provider needs. Then, a post implementation survey (Appendix 4) was anonymously 
administered to the same staff to assess a change in knowledge and practice with the addition of 
questions that assessed their satisfaction with the quality improvement project. In addition, a 
retrospective chart review on patient data were also compared pre and post intervention to 
determine the rates of early termination of the implant using the electronic health record, with 
patients selected based on the International Classification of Disease, Tenth Edition (ICD-10) 
code.  
Program design components. 
 The current education was inconsistent at NRC, using a video from the manufacturer and 
non-structured provider counseling on potential side effects before implant placement. Also, 
patients did not receive any written material as part of the educational process at the NRC prior 
to this project. Therefore, a PowerPoint was distributed during an educational session to review 
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the current system problems regarding inconsistent education about possible irregular or 
prolonged bleeding and potential treatment of irregular bleeding including the addition of 
combined oral contraceptive pills, progestogen only oral pill, or NSAID (non-steroidal anti-
inflammatory drug).  It also focused on the importance of provider contact. An educational 
brochure was specifically developed for the patients who chose the NexplanonÒ implant in 
English (Appendix 1) and in Spanish (Appendix 2).  The Spanish version was translated by the 
certified translator at the NRC. The brochure provided information on the potential side effects, 
treatment options, and contact information for the providers at the NRC.  The brochure was 
reviewed and approved by the providers for distribution to patients. They felt the information it 
provided patients was a useful and vital tool for the clinic. During the implementation phase, 
providers were asked to provide all patients with this brochure during their education of the 
subdermal implant.  This was in conjunction with the current video that patients viewed before 
insertion.  
 After a 60-day implementation period, a post survey (Appendix 4) was administered to 
assess if staff felt they had improved knowledge of correct counseling for the subdermal implant 
and determine if the staff were satisfied with the new education plan.  Also, a chart review was 
conducted on patients who received a subdermal implant during this time.  Data were collected 
on the number of patients that had the implant placed, the number discontinued during the 
implementation phase, and the patients’ reason for discontinuing the implant. These data were 
compared to retrospective data from January 1, 2017 to June 30, 2017 of patient charts with 
NexplanonÒ insertions to determine if there was a difference in early removals between the two 
groups. 
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Setting  
 The current project was conducted at the Northern Regional Center (NRC), a branch of 
the Wake County Public Health Department, located in Wake Forest, N.C.  The clinic is one of 
five health department clinics that provides services to residents of Wake County and 
surrounding areas.  The NRC manages a large population of gynecological and obstetrical 
patients.  
Subjects  
 The current project targeted the staff at the NRC who insert and educate females age 18 
through child bearing years on the subdermal contraceptive implant.  
Ethical Considerations 
This project was granted exemption after review by the University’s Institutional Review 
Board.  There was also a de-identification of data on total number of patients with subdermal 
implants placed, both before and after the implementation period and the number of implants 
discontinued early.  Neither patient nor staff identifiers were collected, assuring patient and staff 
of confidentiality and anonymity. 
Procedure  
 A pre-intervention survey was administered to the providers at NRC to determine current 
education procedures and any inconsistencies from recommendations in current literature.  Based 
on survey results, a system wide education plan was developed to provide an in-depth review of 
irregular vaginal bleeding and potential treatments, and provision of provider contact information 
for patients receiving the subdermal implant.  The education plan was implemented in 
conjunction with the current manufacturers’ video that the patients view before insertion. During 
an in-person meeting, the providers were instructed on how to provide patients with the 
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developed educational program and brochure using a power point presentation.  The educational 
brochure was provided to all patients who received the subdermal implant during the 60-day 
period.   
 The project introduced the educational intervention that was implemented in phases from 
November 3, 2017 to January 11, 2018.  
 Phase I: The framework for implementing a change started in this phase with project 
management (Scbifalacqua, Costejo, & Denman, 2009).  It involved developing a detailed plan 
or draft guideline of the proposed change, which was given to everyone likely to be affected.  All 
stakeholders involved received a copy of the proposed change including the clinic providers and 
nursing staff at the NRC.  After reviewing the outline, there was a need to develop a timeline for 
the plan and an agreement established by the stakeholders.  
Phase II: At this stage, motivation and capacity for change were assessed.  It involved 
communicating with those who might be affected, responding to concerns and, if required, 
justifying the change.  The next step was identifying the team members who would assist in the 
development, evaluation, and implementation of the practice change (Brown, 2014).  For this 
problem, the team consisted of providers (nurse practitioner and medical doctor) and nursing 
support staff.  After identifying the team, the pilot practice change was created, approved based 
on current need and supporting evidence, then implemented. 
Setting up a meeting with staff at the NRC to get their opinions was the main priority.  
The healthcare field is known to be resistant to change so this stage was absolutely necessary 
(Dent and Galloway-Goldberg,1999).  Knowing the barriers to change can allow for a plan that 
is adapted to fit the specific needs of this clinic. Encouraging staff to provide input was important 
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to establish buy-in and a feeling of inclusion (Vahdat, Hamzehgardeshi, Hessam, & 
Hamzehgardeshi, 2014). 
 Phase III: Assessing the change agent’s motivation was Lippitt’s focus of this phase. 
Managers are not always the change agent, and they do not have to be a part of the organization 
where the change is being introduced (Brown, 2014).  The staff at the NRC were the change 
agent for the current project.  Educating providers and offering them the tools necessary for 
implementing the change was the responsibility of the principal investigator.   
 Phase IV: The planning stage was the phase during which the process for change was 
outlined and a final draft was developed.  Review from all stakeholders was important so 
everyone shared responsibility in the entire process. A meeting was scheduled at the NRC with 
all invested members and a consensus was reached on the plan for change.  
 Phase V: Phase five was where an appropriate role was chosen for the change agent.  
Cork (2005) says that change agents are an active part of the change process, particularly in 
terms of managing staff and supporting change, and aimed to transform intentions into actual 
change efforts at this stage.  As the change agent, the investigator was responsible for creating 
the educational tool and instructing the providers to give patients the tool during insertion of the 
subdermal implant.  The role of the change agent was to remain active until the completion of the 
project. 
 Phase VI: This phase corresponded to the implementation stage of the nursing process 
and was concerned with maintaining the change so that it became a stable part of the system.  
Change agents need to use their interpersonal skills to inspire change (Cork, 2005).  During this 
phase, the investigator placed emphasis is on communication, feedback on progress, teamwork, 
and motivation.  
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 Phase VII: The final phase, terminating the helping process, is evaluation and 
withdrawal of the change agent on an agreed date (Lippitt et al., 1958). Roussel (2006) 
recommends that change agents remain available for advice and reinforcement, because past 
behaviors can re-emerge and render even successful change useless.  For purposes of the project, 
the investigator made regular contact with staff over the course of 2 weeks to be of assistance or 
answer any questions the staff may have regarding patient education, side effects, or the created 
brochure. 
Data Collection 
 A survey was developed to test knowledge pre (Appendix 3) and post (Appendix 4) 
implementation of the educational program and provider satisfaction post implementation. The 
survey was aimed at identifying the gaps in current practice in order to design the educational 
program to correlate with the current literature of evidence.  Pre and post data on insertion rates 
and early removal rates were obtained from the health department for comparison using a 
Microsoft ExcelÒ spreadsheet. A retrospective chart audit was done using ExcelÒ to collect pre-
intervention data. The following data were obtained: number of implants placed, number 
removed, and reason for removal. These data were collected during the implementation period 
(November 3, 2017-January 11, 2018) and for a six-month period prior to implementation.  
A qualitative approach was also used during this project to capture the staff experiences 
in a personal and social context and gain a greater understanding of the factors influencing these 
experiences. Collecting data in this way can help providers to understand both provider and 
patient experiences with health and illness and offer compassionate, relationship-centered care 
(Addo & Eboh, 2014). Relationship-centered care is defined as health care that focuses on four 
types of relationships that the provider needs to address in the health care services that they 
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provide: the relationship with the patient; relationships with other providers; relationships with 
the community; and the provider’s relationship to him or herself (Beach and Inui, 2006). This 
theory of relationship-centered care focuses on the entire care team to extend care from the 
individual patient to the community as an entire population (Nundy and Oswald, 2014).  
Data Analysis 
Data were analyzed using the statistical package for the social sciences (SPSS) software, 
version 21.0 (IBM SPSS). Results to pre and post surveys were expressed as percentages. 
Quantitative variables were expressed as means and standard deviations and were compared 
using a two sample t-test with a p value of 0.05. The two sample t-test was used to determine 
whether the educational intervention was statistically significant when comparing pre and post 
intervention implant removal rates of different population sizes. Analysis was also conducted 
using frequencies, percentages, and a Wilcoxon signed-rank test at 0.05 level of significance. The 
Wilcoxon signed-rank test was used to determine whether the educational intervention 
significantly influenced the current practice of counseling female patients age 18 through child 
bearing years who use the subdermal NexplanonÒ implant contraceptive.  
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CHAPTER 5: DATA ANALYSIS 
Before developing the educational program for implementation, staff (N=4) were 
provided a survey to assess knowledge and identify current practice when counseling adult 
female patients of childbearing age about a subdermal contraceptive implant. Table 1 provides a 
summary of the distribution of staff’s responses based on the pre-survey.  
Table 1. Distribution of Pre-Survey Responses 
 Strongly 
Disagree 
Disagree  Neither 
Agree or 
Disagree  
Agree  Strongly 
Agree 
1. I am familiar with 
evidence-based practices 
on counseling patients that 
receive the Nexplanon 
subdermal contraception 
implant. 
0 %      0 %     50 %   25 %   25 %   
2. I am familiar with 
common Nexplanon side 
effects and the effect on 
correct use of the implant. 
0 %      25 %   25 %   25 %    25 %     
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3. I am comfortable 
counseling patients on 
potential side effects with 
the Nexplanon implant. 
0 %      0 %     25 %   50 %    25 %   
4. I treat irregular bleeding 
as thorough as possible 
before removing the 
Nexplanon implant. 
0 %      0 %     25 %   50 %     25 %    
5. I provide patients with 
my contact information 
before they leave the 
appointment. 
0 %      0 %     25 %    50 %    25 %   
6. I understand the 
importance of in-depth 
education for patients who 
chose the Nexplanon 
implant. 
0 %      25 %   25 %   50 %    0 %     
7. Patients acknowledge 
that they will contact me 
with any undesirable side 
effects. 
0 %      0 %     25 %   50 %    25 %   
Table 1 
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Following completion of the pre-survey, an educational program was developed and 
implemented. This program focused on provider-led counseling methods to address irregular 
and/or prolonged bleeding with the subdermal implant, including treatment options, and a patient 
brochure. After implementation of this educational program, the staff were asked to take another 
survey. Table 2 provides the distribution of participants’ responses based on the post-survey. 
Table 2. Distribution of Post-Survey Responses 
 Strongly 
Disagree 
Disagree  Neither 
Agree or 
Disagree  
Agree  Strongly 
Agree 
1. I am familiar with evidence-
based practices on counseling 
patients that receive the 
Nexplanon subdermal 
contraception implant. 
0 %     0 %      0 %     25 %    75%    
2. I am familiar with common 
Nexplanon side effects and the 
effect on correct use of the 
implant. 
0 %     0 %      0 %     25 %    75%    
3. I am comfortable counseling 
patients on potential side 
effects with the Nexplanon 
implant. 
0 %     0 %      0 %     50 %    50 %    
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4. I treat irregular bleeding as 
thorough as possible before 
removing the Nexplanon 
implant. 
0 %     0 %      0 %     50 %      50 %       
5. I provide patients with my 
contact information before 
they leave the appointment. 
0 %     0 %      0 %     25 %     75%    
6. I understand the importance 
of in-depth education for 
patients who chose the 
Nexplanon implant. 
0 %     0 %      0 %     25 %    75%    
7. Patients acknowledge that 
they will contact me with any 
undesirable side effects. 
0 %     0 %      25 %   25 %    50 %   
Table 2 
The first item assessed the participants’ perceived knowledge of evidence-based practices 
related to counseling patients who receive the NexplanonÒ subdermal contraception implant. 
Before the educational intervention, half of the participants (50%) neither agreed nor disagreed 
with the Item 1 statement: I am familiar with evidence-based practices on counseling patients 
that receive the NexplanonÒ subdermal contraception implant. The rest of the participants 
agreed (25%) and strongly agreed (25%) with this statement and none of the participants 
disagreed. After the educational intervention, the majority of the participants (75%) strongly 
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agreed they were aware of the evidence-based practices for women receiving NexplanonÒ while 
25% agreed with the statement in Item 1.  
Item 2 assessed the participants’ perceived familiarity with the side effects of using the 
NexplanonÒ subdermal contraception implant and the effects on the correct use of the 
contraceptive. Based on the pre-survey, half of the staff either agreed (25%) or strongly agreed 
(25%) that they were familiar with the side effects of NexplanonÒ and the effects when it is 
correctly used. An additional 25% neither agreed nor disagreed, while 25% disagreed with Item 
2. After the educational intervention, there was a 50% increase in the number of staff who 
strongly agreed (75%) that they were familiar with the common side effects of NexplanonÒ and 
the effects of correctly using the implant. The remaining 25% of staff survey respondents agreed 
that they were familiar with the common side effects of NexplanonÒ and the effects of correctly 
using the contraceptive.  
Item 3 evaluated respondents’ perceptions regarding counseling on the potential side 
effects of the NexplanonÒ subdermal implant. Before the intervention, half of the participants 
(50%) agreed that they were comfortable with counseling about the potential side effects of the 
NexplanonÒ implant, while 25% strongly agreed and 25% of the staff neither agreed nor 
disagreed that they were comfortable with this counseling. No participants disagreed with Item 3 
on the pre-survey. After the educational intervention, half of the staff (50%) agreed and the other 
half (50%) strongly agreed that they were comfortable with counseling on the potential side 
effects of using NexplanonÒ.  
Item 4 measured the participants’ treatment of irregular bleeding before the removal of 
the NexplanonÒ implant. Prior to the educational intervention, 50% and 25% of the participants 
agreed and strongly agreed, respectively, that they treated irregular bleeding as thoroughly as 
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possible before removing the NexplanonÒ implant. The remaining 25% of respondents neither 
agreed nor disagreed with this statement. None (0%) of the participants disagreed that they 
treated irregular bleeding as thorough as possible before removing NexplanonÒ. After the 
educational intervention, half of the participants (50%) agreed and half (50%) strongly agreed 
that they treated irregular bleeding as thorough as possible before removing the NexplanonÒ 
implant.  
Item 5 assessed whether the participants provided patients with their contact information 
before concluding the appointment. Based on the pre-survey findings, half of the participants 
(50%) agreed and 25% strongly agreed that they provide their contact information to patients 
before they leave appointment. The rest of the participants (25%) neither agreed nor disagreed 
with the statement they provide their contact information to patients before leaving 
appointments. After the educational intervention, three-quarters of the participants (75%) 
strongly agreed that they provided contact information to their patients before leaving an 
appointment. The rest of the participants (25%) agreed that they provided contact information to 
their patients before leaving appointments.  
Item 6 tested the participants’ understanding of the importance of in-depth education for 
patients who opt to use the NexplanonÒ implant. Based on the pre-survey, half (50%) of the 
participants agreed with the statement: “I understand the importance of in-depth education for 
patients who choose the NexplanonÒ implant.” An additional 25% of the participants neither 
agreed nor disagreed with this statement and 25% disagreed with this statement. After the 
educational intervention, 75% of the participants strongly agreed and 25% agreed that they 
understood the importance of in-depth education for patients using the NexplanonÒ implant.  
 
 
28 
Item 7 assessed whether the patients acknowledged to the staff that they would contact 
their providers if they experience undesirable side effects. Based on the pre-survey, 50% agreed  
and 25% strongly agreed that patients acknowledged that they would contact them in case of 
undesirable side effects. However, 25% neither agreed nor disagreed with this item. After the 
educational intervention, half of the participants (50%) strongly agreed that patients 
acknowledged they would contact them when faced with undesirable side effects while 25% 
agreed and 25% neither agreed nor disagreed with Item 7. 
The post-survey had three additional questions to evaluate for changes in providers’ 
practice of counseling and in patients’ choice of contraception as well as patient response to the 
brochure. These questions were intended to address sustainability of the practice change and staff 
perception of the education.  Table 3 shows the distribution of the three additional questions in 
the post-survey. 
Table 3. Distribution of Post-Survey Responses for Items 8-10 
 Strongly 
Disagree 
Disagree  Neither 
Agree or 
Disagree  
Agree  Strongly 
Agree 
8. My current practice for 
counseling patients on the 
potential side effects for the 
Nexplanon implant has 
changed since the initial 
education plan 
0 %     25 %   25 %   25 %   25 %    
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9. Patients are choosing the 
Nexplanon less as their 
contraception of choice after 
they learn about the 
potential side effects.  
25 %   25 %   25 %   25 %   0 %      
10. The brochure created for 
patients to take home has 
been received well by 
patients and beneficial to 
the practice. 
0 %     0 %      0 %     75%    25 %    
Table 3 
Item 8 evaluated whether staff agreed or disagreed with the statement: My current 
practice for counseling patients on the potential side effects for the NexplanonÒ implant has 
changed since the initial education plan. Staff responses to Item 8 on the post-survey were 
varied, with 25% strongly agreeing, 25% agreeing, 25% neither agreeding nor disagreeing and 
25% disagreeing with Item 8.  
Item 9 evaluated for staff perceptions of patients choosing the NexplanonÒ implant less 
frequently after learning of the potential side effects. Based on the responses, 25% of the staff at 
the NRC agreed that patients choose the NexplanonÒ implant less frequently after learning about 
the potential side effects. An additional 25% were neutral (neither agreed nor disagreed) on this 
aspect, disagreed (25%) or strongly disagreed (25%) that the patients were less likely to choose 
the NexplanonÒ implant after learning of the potential side effects.  
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Item 10 was used to assess the perceptions of whether the brochure meant for the patients 
had been received well and its benefits to the practice. Based on the post-survey, all the staff 
either agreed (75%) or strongly agreed (25%) that the brochure created for the patients to use at 
home was well-received by the patients and was beneficial to the practice.  
A Wilcoxon signed-rank test was conducted to determine whether there was a significant 
difference between the pre-survey and post-survey scores. Table 4 provides a summary of the 
comparison between the staff’s rankings before and after the educational intervention.  
Table 4. Wilcoxon Signed-Rank Test  
 N Mean Rank Sum of Ranks 
PostSurvey - PreSurvey Negative Ranks 0a .00 .00 
Positive Ranks 7b 4.00 28.00 
Ties 0c   
Total 7   
a. PostSurvey < PreSurvey 
b. PostSurvey > PreSurvey 
c. PostSurvey = PreSurvey 
Table 4 
As shown in Table 4, the staff’s post-survey scores were higher than the pre-survey 
scores. None of the items had higher scores in the pre-intervention stage compared to the period 
after the implementation of the educational program. Table 5 provides a summary of the test 
statistics for the Wilcoxon signed-rank test.  
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Table 5. Test Statistics 
 Post Survey – Pre Survey 
z -2.371 
Asymp. Sig. (2-tailed) .018 
Table 5 
Based on the Wilcoxon test, an educational program for providers to counsel patients on 
the subdermal contraceptive implant and its common side-effects in females of childbearing age 
elicited a statistically significant change in knowledge among participants at the NRC (z = -
2.371, p = 0.018).  
Qualitative Participant Feedback 
This quality improvement project also involved the collection of feedback from the staff 
members after the post-survey. Before the educational intervention, there was an overall 
disconnect and dissatisfaction with the current practices for patients using the NexplanonÒ 
implant. The providers stated the current practices at the NRC were “inconsistent”  and that “the 
video provided to educate patients on the implant was lengthy,” therefore staff felt that “the 
patients did not pay close attention.” During informal interviews with clinic staff and from three 
questions on the post-survey (Appendix 4) several themes emerged in their feedback.  
Staff were asked if they identified more patients declining the NexplanonÒ implant due 
to its potential side effects. One participant wrote, “No, I say to the patient that we can give pills 
to decrease vaginal bleeding so they are o.k. with that and want to try the Nexplanon.”The next 
question asked staff if they suggested an alternative method of contraception due to the patient’s 
repsonse to potential side effects. One participant wrote, “I always go over all LARCs. If the 
patient doesn’t want to try either of them, I suggest OCPs, the patch, or condoms.”  
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The staff indicated that the brochure created was beneficial to patients and it was also 
beneficial to identifying patients that may not tolerate the side effects of the implant. Staff also 
indicated that the brochure was succinct and portable which allowed patients to carry them 
home, and was designed for a shorter attention span, which was helpful during counselling 
sessions. Participants were asked if they changed the way they discussed and counselled patients 
on the NexplanonÒ implant. This question was evaluating for specific examples of how the new 
education program changed the staff’s approach to counseling patients on the subdermal implant.  
One participant wrote, “Yes, I give them the handout which helps them to see the side effects in 
a written short format. The handout and video that I currently show to the patient is more in 
depth but I don’t think the patient always pays attention due to the length of it.” 
 Prior to this project, there were no educational materials in Spanish. This limited the 
users to only patients who could read and understand English. Participants were asked if the 
availability of the brochure in Spanish was helpful. All participants agreed this was helpful and 
one wrote, “it was a good resource for our Hispanic patients, something they could easily read 
and comprehend.” 
Retrospective Chart Review 
The current project also involved the analysis of patient chart audits before 
implementation of the educational program. During a 6 month review period, from January 1, 
2017 to June 30, 2017, there were a total of 20 implants that were removed from female patients 
age 18 through child bearing years. Of these 20 patients, 14 (70%) were non-Hispanic and 6 
(30%) were Hispanic. This suggested that the brochure should also be created in Spanish for 
patients who may prefer receiving health information in this language. The reasons for 
discontinuation due to side effects were also documented and included: irregular menses 
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(37.5%), headache (25%), site issues (25%), and depression (12.5%). Irregular bleeding was the 
most common reason for early removal and, as a result, was the primary focus of the provider-
led educational program. 
Table 6 provides a summary of the results based on the paired samples t-test on the 
retrospective chart audit completed on female patients age 18 through child bearing years. Due to 
unequal sample sizes a two sample t-test was used to compare pre and post implementation data. 
The educational intervention had a significant impact on the implants removed (p = 0.015), but 
not on the implants discontinued early (p = 0.081).  
Table 6. Pre- and Post-Implementation Chart Audit Results  
Table 6 
 
 
  
      t  df Sig. (2-
tailed  
Implants removed     -3.000  9                0.015    
Implants discontinued early  -1.954        9 0.081 
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CHAPTER 6: DISCUSSION 
Subdermal contraceptive implants may be used to delay and prevent unwanted 
pregnancy, providing healthcare providers with effective options to offer patients when 
reviewing their reproductive choices (Secura et al., 2010; Mosher & Jones, 2010). Poor tolerance 
to changes in vaginal bleeding associated with hormonal contraceptive use may influence 
compliance and continuation with subdermal and other contraceptives (Bachmann & Korner, 
2009; Dickson et al., 2014; Garbers et al., 2012; Lunde et al., 2017; and Moreau et al., 2007).  
Counseling women on expected bleeding patterns has been shown to improve continuation rates 
for implantable progestogen contraceptives (Bachmann & Korner, 2009; Carek et al., 2013; 
Harvey et al., 2009; Lunde, et al., 2017). Relationship centered-care is integrating the entire 
system to optimize overall population health (Nundy & Oswald, 2014).  This quality 
improvement project worked with the entire care team to illicit feedback for creation of the 
educational program. It focused on the providers, staff, the system, and patients to create a 
change in the overall process that made it more efficient and consistent.  
Key Findings 
 The results indicated an improvement in the percentage of staff members who 
understood side effects of the NexplanonÒ implant (75%) after implementation of the 
educational program, whereas before, 50% of the staff neither agreed or disagreed that they were 
familiar. Further analysis indicated that the educational program for staff significantly improved 
staff knowledge at the NRC (p < 0.018). Increasing continuation rates of the subdermal implant 
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was not the main focus of the project but there was interest if the educational program would 
improve this rate. After completeing the retrospective chart review, the number of implants 
removed before and after implementation of the educational program was statistically significant 
(p = 0.015). The system wide quality improvement project to optimize counseling patients about 
the subdermal contraceptive implant was effective in increasing staff knowledge of side effects, 
potential treatment options, and the importance of providing patients with contact information at 
their appointment and decreasing early termination of the implant. This is important since studies 
prove that counseling women on side effects such as excessive bleeding could improve 
continuation rates for contraceptives (Dickson et al., 2014; Lunde et al., 2017; Secura et al., 
2010).  
 There was also an increase in the proportion of staff who were comfortable with 
counseling patients about the potential side effects of using the NexplanonÒ subdermal implant 
after implementation of the educational program (50%), increased from 25%. This finding was 
supported by various reaserchers in previous studies who identified the need for and importance 
of extensive educational programs for patients who use subdermal implants (Dickson et al., 
2014; Garbers et al., 2012; Lunde et al., 2017; and Moreau et al., 2007). Therefore, 
implementing the educational program was beneficial to the staff members as it enhanced their 
knowledge and awareness regarding the side effects of NexplanonÒ and the importance of 
maintaining communication with patients who use the contraceptive.  
Harvey et al. (2009) suggested that provider educational and counseling interventions can 
significantly improve the management of excessive bleeding for patients who use subdermal 
implants, preventing early discontinuation of subdermal implant contraceptives. Another finding 
from the current project was the increase in the proportion of providers who treated irregular 
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bleeding as thoroughly as possible before removing the NexplanonÒ implant (50%), while prior 
to implementation, only 25% strongly agreed. One participant shared, “I make sure I always 
offer OCPs to treat irregular bleeding if the patient is willing to continue with the implant, if not, 
I will remove it.” 
 After the educational intervention, there was an increase in the proportion of staff 
members who provided their contact information to patients in writing via the brochure before 
leaving an appointment (75%). Before the implementation, only 25% strongly agreed to 
providing this information to patients during the apppointment. This is important because 
patients’ report having provider contact information for questions and follow-up as being crucial 
to their care (Lunde et al., 2017).  In addition, there was an increase in the proportion of staff 
members who stated that their patients acknowledged contacting them in case of undesirable side 
effects of the NexplanonÒ implant (50%). Prior to implemtation, only 25% agreed that their 
patients acknowledged contacting them.  
The majority of staff members also perceived that the brochure meant for the patients was 
well-received and beneficial to the NRC, with all the staff eithering agreeing (75%) or strongly 
agreeing (25%).  The need for clear written instructions on side effects, treatment options, and 
provider contacts have been proven useful by women (Lunde et al., 2017).  With 30% of the 
clinic seeing Spanish speaking patients, having a brochure that they could read was imperative to 
reach this population. One participants stated, “our Spanish speaking patients appreciated having 
a resource that was easy to read and that they could take home with them.”  
 Comments from staff were also beneficial to the success of the project and its 
sustainability at the NRC. Qualitative data is valuable for an increased understanding of the 
effects of the quality improvement intervention that takes in the practice, as well as providing the 
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data about why and how the planned education succeed or not (Addo & Eboh, 2014). Qualitative 
feedback from staff identified the brochure developed as a helpful and valuable educational tool 
that staff easily incoprorated into the routine of subdermal contraceptive counseling. This is 
important in promoting the sustainability of practice changes associated with this quality 
improvement project. Sustaining the efforts of practice change at the NRC is essential to ensure 
that patients receive the best care possible but also to ensure that investments made in knowledge 
acquisition and transfer are not wasted (Virani, Lemieux-Charles, Davis, & Berta, 2009).  
Implications for Practice 
Unplanned pregnancy is a major public health issue in young American women of the 
reproductive age (Finer & Zolna, 2016; Jacobstein & Stanley, 2013).  However, the introduction 
of subdermal implants such as NexplanonÒ provides women with a highly effective, safe, 
convenient, and long-term alternative contraceptive method (American College of Obstetricians 
and Gynecologists, 2017; Dodson, Gray, & Burke, 2012; Secura et al., 2010). Though most 
women are satisfied with the services they receive from care providers, it is important to ensure 
that providers understand these implants, their potential side effects, and maintain effective 
communication during and after appointments (Bachmann & Korner, 2009; Carek et al., 2013; 
Dickson et al., 2014; Harvey et al., 2009; Lunde et al., 2017). 
Providers had increased levels of knowledge of the evidence-based practices related to 
counseling patients who use NexplanonÒ subdermal contraception implant after implementation 
of the educational program. Improving provider knowledge of subdermal implant contraceptives  
enhanced their comfort when counseling patients and effectively promoted implant continuation. 
The educational program also promoted the providers’ likelihood of providing patients with  
contact information during appointments. Providing patients with providers’ contact information 
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improves communication and ensures prompt responses in case of adverse side effects of the 
NexplanonÒ implants (Lunde et al., 2017). The findings of the current study imply that the 
implementation of educational programs to improve providers counseling of women who use 
subdermal implants can positively influence provider knowledge and comfort with subdermal 
contraceptive counseling and improve compliance with better management of side effects.  
Recommendations 
 Future studies should focus on the role of patient perceptions regarding the subdermal 
NexplanonÒ implants and the effectiveness of educational interventions in promoting the 
continuation of these contraceptives. The current quality improvement project only partially 
revealed the indirect effects of provider education on implant continuation by patients of child-
bearing age. Therefore, future studies should aim to address the direct link between counseling 
patients on the benefits of side effects of the NexplanonÒ implants and continuation. Future 
studies should employ a larger sample size to improve generalizability of findings. Overall, the 
expanded implementation of educational programs for providers to promote counseling patients 
who use NexplanonÒ implants can significantly enhance continuation of the contraceptives 
reducing the rate of unwanted pregnancies and abortions (Lunde, et al., 2017).  
As interviewing is becoming more common practice to explore and understand the 
patient’s subjective experiences, the verbal and written communication in relationship-centered 
care provides great insignt in to system change (Suchman and Williamson, 2010). In this quality 
improvement project, relationship-centered care offered a means to ensure that each provider 
offered each patient the same education and counseling at every visit (Suchman and Williamson, 
2010). The model included all members of the system and engaged all with the notion of 
effective care, a primary goal of relationship-centered care (Suchman and Williamson, 2010).  
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Limitations 
 The current project may have several limitations.  First, it was conducted at a single 
clinic with a small convenience sample.  This limits the generalizability of the findings of this 
project. Given that this project was limited in its timeframe, the sustainability of the staff 
knowledge remains unknown.  Response bias was also a risk since the sample was a small 
sample where one of the providers recruited the staff members. The clinic staff was initially 
unsure about the need for change, so the same provider was responsible for engaging the staff. 
Lastly, the number of implants removed was statistically significant (p = 0.015), but the number 
of implants discontinued early was not (p = 0.081). This is likely due to the population size of the 
sample so future quality improvement projects should focus on larger systems. 
Conclusion 
Local health departments play a vital role in providing contraceptive care for women. To 
help prevent unintended pregnancies, integrating LARC services into primary care-focused 
health clinics is necessary. The implementation of the current project significantly improved staff 
members’ knowledge and awareness of counseling patients about the NexplanonÒ implant, its 
common side effects, and the exchange of contact information at the NRC. Provider training and 
patient counseling to dispel misconceptions regarding LARC use has been shown to improve 
usage and continuation rates of LARC contraception (Arrowsmith, M., Aicken, C., Saxena, S., & 
Majeed, A., 2012; Garbers et al., 2013). To help women make an informed decision about 
contraception use, providers need to eliminate misconceptions and provide evidence-based 
information to educate women about LARC methods and access. All of these steps will help 
reduce unintended pregnancy, help to increase contraceptive use and adherence, and promote 
healthy behaviors. 
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APPENDIX 1: NEXPLANON PATIENT BROCHURE 
 
Nexplanon 
Birth Control 
Implant 
 
   
What you need to know about 
Nexplanon... 
A patient’s guide for subdermal contraception. 
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APPENDIX 1: NEXPLANON PATIENT BROCHURE 
 
Nexplanon 
 
What is Nexplanon? 
Nexplanon is about the size of a matchstick, is made of soft plastic and is inserted just beneath the skin on the inner side of the 
upper arm by a healthcare provider during an in-office procedure. Nexplanon continually releases a low, steady dose of progestin 
(etonogestrel) to prevent pregnancy for up to 3 years. 
 
Common Side Effects 
Irregular bleeding is the most common side effect. Some women have more bleeding, less bleeding, or no bleeding. The time 
between periods may also vary, and in between periods, you may have spotting. If irregular bleeding becomes intolerable, there 
may be additional treatments your provider can prescribe. 
 
Provider Contact  
Please contact your provider with any questions/concerns at the Northern Regional Center by calling (919)562-6300.  
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APPENDIX 2: NEXPLANON PATIENT BROCHURE IN SPANISH 
 
Nexplanon 
Implante para el 
Control de la 
natalidad 
 
   
Que necesita saber sobre el 
Nexplanon... 
Guia para el paciente de la anticoncepción subcutánea. 
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APPENDIX 2: NEXPLANON PATIENT BROCHURE IN SPANISH 
 
Nexplanon 
 
¿ Nexplanon? 
Nexplanon es un método de control natal que libera bajas dosis de estrogen para prevenir el embarazo durante 4 años.  
Nexplanon es del tamaño de un fósforo, hecho de plástico suave que se introduce debajo de la piel en el lado interno del brazo 
durante la visita médica. 
 
Efectos secundarios 
Algunos efectos secundarios: Period sangrado irregular, es decir; depende de cada mujer; algunas sangran mucho, otas poco y 
otras no sangran. Si su sangrado es intolerable, contacte a su medico y le recomendará medicina para controlarlo. 
 
Contacto del proveedor  
Si tiene preguntas, no dude en llamar al Centro regional de Salud del Norte de Wake County (NRC) al  (919)562-6300.  
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APPENDIX 3: NRC NEXPLANON PRE-EDUCATION SURVEY 
1. I am familiar with evidence-based practices on counseling patients that receive the Nexplanon 
subdermal contraception implant. 
(a) Strongly disagree (b) Disagree (c) Neither agree or disagree (d) Agree (e) Strongly agree 
2. I am familiar with common Nexplanon side effects and the effect on correct use of the 
implant. 
(a) Strongly disagree (b) Disagree (c) Neither agree or disagree (d) Agree (e) Strongly agree 
3. I am comfortable counseling patients on potential side effects with the Nexplanon implant. 
a) Strongly disagree (b) Disagree (c) Neither agree or disagree (d) Agree (e) Strongly agree 
4. I treat irregular bleeding as thorough as possible before removing the Nexplanon implant. 
a) Strongly disagree (b) Disagree (c) Neither agree or disagree (d) Agree (e) Strongly agree 
5. I provide patients with my contact information before they leave the appointment. 
a) Strongly disagree (b) Disagree (c) Neither agree or disagree (d) Agree (e) Strongly agree 
6. I understand the importance of in-depth education for patients who chose the Nexplanon 
implant. 
a) Strongly disagree (b) Disagree (c) Neither agree or disagree (d) Agree (e) Strongly agree 
7. Patients acknowledge that they will contact me with any undesirable side effects. 
a) Strongly disagree (b) Disagree (c) Neither agree or disagree (d) Agree (e) Strongly agree 
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APPENDIX 4: NRC NEXPLANON POST-EDUCATION SURVEY 
1. I am familiar with evidence-based practices on counseling patients that receive the Nexplanon 
subdermal contraception implant. 
(a) Strongly disagree (b) Disagree (c) Neither agree or disagree (d) Agree (e) Strongly agree 
2. I am familiar with common Nexplanon side effects and the effect on correct use of the 
implant. 
(a) Strongly disagree (b) Disagree (c) Neither agree or disagree (d) Agree (e) Strongly agree 
3. I am comfortable counseling patients on potential side effects with the Nexplanon implant. 
a) Strongly disagree (b) Disagree (c) Neither agree or disagree (d) Agree (e) Strongly agree 
4. I treat irregular bleeding as thorough as possible before removing the Nexplanon implant. 
a) Strongly disagree (b) Disagree (c) Neither agree or disagree (d) Agree (e) Strongly agree 
5. I provide patients with my contact information before they leave the appointment. 
a) Strongly disagree (b) Disagree (c) Neither agree or disagree (d) Agree (e) Strongly agree 
6. I understand the importance of in-depth education for patients who chose the Nexplanon 
implant. 
a) Strongly disagree (b) Disagree (c) Neither agree or disagree (d) Agree (e) Strongly agree 
7. Patients acknowledge that they will contact me with any undesirable side effects. 
a) Strongly disagree (b) Disagree (c) Neither agree or disagree (d) Agree (e) Strongly agree 
8. My current practice for counseling patients on the potential side effects for the Nexplanon 
implant has changed since the initial education plan? 
a) Strongly disagree (b) Disagree (c) Neither agree or disagree (d) Agree (e) Strongly agree 
9. Patients are choosing the Nexplanon less as their contraception of choice after they learn about 
the potential side effects.  
a) Strongly disagree (b) Disagree (c) Neither agree or disagree (d) Agree (e) Strongly agree 
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APPENDIX 4: NRC NEXPLANON POST-EDUCATION SURVEY (Continued) 
10. The brochure created for patients to take home has been received well by patients and 
beneficial to the practice. 
a) Strongly disagree (b) Disagree (c) Neither agree or disagree (d) Agree (e) Strongly agree 
 
Please answer to the best of your ability, giving examples if necessary:  
With implementation of the new education plan, have you: 
1. Identified more patients declining the Nexplanon implant due to its potential side effects? 
2. Suggested an alternative method of contraception due to the patient’s response to 
potential side effects?  
 
3. Changed the way you discuss and counsel patients on the Nexplanon implant? 
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